Northwestern Mutual Wealth Management’s Autolus Therapeutics AUTL Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.92K	Buy	+3,700	New	+$5.8K	﹤0.01%	3319
2023 Q3	–	Sell	-100	Closed	-$238	–	3287
2023 Q2	$238	Buy	+100	New	+$237	﹤0.01%	3228
2022 Q3	–	Sell	-500	Closed	-$1K	–	3112
2022 Q2	$1K	Buy	+500	New	+$1.52K	﹤0.01%	2996
2022 Q1	–	Sell	-200	Closed	-$1K	–	3093
2021 Q4	$1K	Hold	200	–	–	﹤0.01%	2998
2021 Q3	$1K	Buy	+200	New	+$1.26K	﹤0.01%	2895

Other funds holding AUTL

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northwestern Mutual Wealth Management's AUTL Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Autolus Therapeutics (AUTL) in Q2 2026: 3,700 shares worth $5.92K. The stake represents ﹤0.01% of the portfolio and ranks #3319 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in AUTL as recently as Q2 2023.

Northwestern Mutual Wealth Management first reported a position in AUTL in Q3 2021 and has held it in 5 quarters since. 83 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

Northwestern Mutual Wealth Management held 3,700 shares of Autolus Therapeutics worth $5.92K as of Q2 2026.
Autolus Therapeutics was a new Northwestern Mutual Wealth Management position in Q2 2026.
Autolus Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3319 holding.
Northwestern Mutual Wealth Management first reported a position in Autolus Therapeutics in Q3 2021 and has held it in 5 quarters since.
83 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.